A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1

This study is ongoing, but not recruiting participants.

Study NCT00267657 Information provided by National Institute on Drug Abuse (NIDA)

First Received: December 20, 2005 Last Updated: October 25, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	November 2004
Estimated Primary Completion Date:	No date given